Ocular Therapeutix™ Announces Success in Patent Appeal Brought by Mati Therapeutics, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: OCUL) | Delayed: 6.50 -0.11 (1.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.61 | 52 Week High | $14.50 | |||
| Open | $6.68 | 52 Week Low | $4.04 | |||
| Day High | $6.68 | P/E | N/A | |||
| Day Low | $6.35 | EPS | $0.00 | |||
| Volume | 1,855,971 | |||||
